series-c-plus
Stage
1
Investors
About
Passage Bio is a clinical-stage gene therapy company focused on developing treatments for monogenic central nervous system diseases.
Explore Passage Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.